Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emerald Health Therapeutics Inc (OP: EMHTF )

0.0405 UNCHANGED
Last Price Updated: 3:42 PM EST, Nov 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0405
Today's Range 0.0405 - 0.0405
52wk Range 0.0200 - 0.0600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile

Performance

YTD
-26.36%
-26.36%
1 Month
+30.65%
+30.65%
3 Month
+16.38%
+16.38%
6 Month
+11.57%
+11.57%
1 Year
-25.82%
-25.82%

More News

Read More
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
Via Newsfile
Topics Derivatives
Exposures Derivatives
The Canadian Cannabis Report - Monday, Sept. 12
Via Talk Markets
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
Via Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Via Newsfile
HYTN Awarded Medical Cannabis Sales License By Health Canada
Via Benzinga
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, July 4
Via Talk Markets
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, June 20
Via Talk Markets
Skye Bioscience Signs Arrangement Agreement With Emerald Health Therapeutics, Here Are The Details
Via Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
Via Newsfile
Topics Derivatives
Exposures Derivatives
The Canadian Cannabis Report - Monday, March 28
Via Talk Markets
HYTN Innovations To Accept Cannabis Orders Directly From Provinces & Territories
Via Benzinga
The Canadian Cannabis Report - Monday, Mar. 7
Via Talk Markets
HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
Via Benzinga
Emerald Health Therapeutics Sells Patents to FlowerPod
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
The Canadian Cannabis Report - Monday, Jan. 3
Via Talk Markets
The Canadian Cannabis Report- Monday, Dec. 27
Via Talk Markets
The Canadian Cannabis Report- Monday, Dec. 20
Via Talk Markets
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
Via Benzinga
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10%
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.